Sight Sciences, Inc. is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Paul Badawi, with a market cap of $189.0M.
Common questions about Sight Sciences, Inc.
Sight Sciences, Inc. is scheduled to report earnings for Q1 2026 on May 7, 2026. Analysts estimate revenue of $18.6M.
Sight Sciences, Inc. has approximately 214 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.